Cargando…

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Impaired beta‐cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of insulin secretory capacity are useful to inform clinical practice, helping to classify types of diabetes, complication risk stratification and to guide treatment decisions. Because C‐peptide secretion m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maddaloni, Ernesto, Bolli, Geremia B., Frier, Brian M., Little, Randie R., Leslie, Richard D., Pozzilli, Paolo, Buzzetti, Raffaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543865/ https://www.ncbi.nlm.nih.gov/pubmed/35676794 http://dx.doi.org/10.1111/dom.14785

Ejemplares similares

Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
por: Strollo, Rocky, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
por: Maddaloni, Ernesto, et al.
Publicado: (2015)

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
por: Owens, David R., et al.
Publicado: (2019)

The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism
por: Mahrooz, Abdolkarim, et al.
Publicado: (2021)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Obesity, Autoimmunity, and Double Diabetes in Youth
por: Pozzilli, Paolo, et al.
Publicado: (2011)

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
por: Buzzetti, Raffaella, et al.
Publicado: (2020)

C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277: An Exploratory Study
por: Buzzetti, Raffaella, et al.
Publicado: (2011)

Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study
por: Defeudis, Giuseppe, et al.
Publicado: (2022)

Assessment of Type 1 Diabetes Risk Conferred by HLA-DRB1, INS-VNTR and PTPN22 Genes Using the Bayesian Network Approach
por: Portuesi, Rosalba, et al.
Publicado: (2013)

Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
por: Napoli, Nicola, et al.
Publicado: (2013)

Diabetes-Related Autoantibodies in Children With Acute Lymphoblastic Leukemia
por: Bizzarri, Carla, et al.
Publicado: (2012)

Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
por: D’Onofrio, Luca, et al.
Publicado: (2023)

Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes
por: D'Onofrio, Luca, et al.
Publicado: (2021)

Hypoglycemia, Diabetes, and Cardiovascular Events
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study
por: Lucidi, Paola, et al.
Publicado: (2011)

Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA
por: Tiberti, Claudio, et al.
Publicado: (2022)

Comparable efficacy with similarly low risk of hypoglycaemia in patient‐ vs physician‐managed basal insulin initiation and titration in insulin‐naïve type 2 diabetic subjects: The Italian Titration Approach Study
por: Bonadonna, Riccardo C., et al.
Publicado: (2020)

Critical need to assess modified and un-modified peptides in C-peptide standard materials
por: Wu, Zengru, et al.
Publicado: (2022)

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
por: Hawa, Mohammed I., et al.
Publicado: (2009)

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
por: Nusca, Annunziata, et al.
Publicado: (2015)

High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja
por: Maddaloni, Ernesto, et al.
Publicado: (2017)

Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes
por: Porcellati, Francesca, et al.
Publicado: (2013)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
por: Maddaloni, Ernesto, et al.
Publicado: (2020)

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
por: Bolli, Geremia B., et al.
Publicado: (2020)

Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication
por: Siddiqui, Khalid, et al.
Publicado: (2022)

Effects of the COVID‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
por: D'Onofrio, Luca, et al.
Publicado: (2021)

Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
por: Nusca, Annunziata, et al.
Publicado: (2021)

Human C-peptide Quantitation by LC-MS Isotope-Dilution Assay in Serum or Urine Samples
por: Stoyanov, Alexander V, et al.
Publicado: (2013)

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2011)

Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis
por: Buzzetti, Raffaella, et al.
Publicado: (2021)

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
por: Owens, David R., et al.
Publicado: (2020)

Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent
por: Gresele, Paolo, et al.
Publicado: (2010)

Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
por: Maddaloni, Ernesto, et al.
Publicado: (2021)

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2012)

Incorporating social determinants of health into individual care—a multidisciplinary perspective of health professionals who work with people who have type 2 diabetes
por: Frier, Amanda, et al.
Publicado: (2022)

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials
por: Porcellati, Francesca, et al.
Publicado: (2017)

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
por: Porcellati, Francesca, et al.
Publicado: (2011)

The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes: The T-emerge 2 trial
por: Rosenstock, Julio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_12hvr0he4l9kpvpgu0tnaqpa13